These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12744193)

  • 21. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
    Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
    Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
    Huckriede A; Bungener L; Holtrop M; de Vries J; Waarts BL; Daemen T; Wilschut J
    Vaccine; 2004 Mar; 22(9-10):1104-13. PubMed ID: 15003637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New tools for antigen delivery to the MHC class I pathway.
    Morón G; Dadaglio G; Leclerc C
    Trends Immunol; 2004 Feb; 25(2):92-7. PubMed ID: 15102368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of antigen size on the immunogenicity of antigen presenting cell targeted DNA vaccine.
    Jia R; Guo JH; Fan MW
    Int Immunopharmacol; 2012 Jan; 12(1):21-5. PubMed ID: 21945335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
    Tang Q; Dou J; Zhao FS; Chu LL; Pan M; Wang YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):591-4. PubMed ID: 17618574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.
    Hauser H; Shen L; Gu QL; Krueger S; Chen SY
    Gene Ther; 2004 Jun; 11(11):924-32. PubMed ID: 15085173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
    Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Shimokawa M; Sugita T; Niwa T; Oda A; Akashi M; Tsutsumi Y; Mayumi T; Nakagawa S
    Biochem Biophys Res Commun; 2004 Dec; 325(2):500-5. PubMed ID: 15530420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses.
    Kwon YJ; Standley SM; Goodwin AP; Gillies ER; Fréchet JM
    Mol Pharm; 2005; 2(1):83-91. PubMed ID: 15804181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The processing of antigens delivered as DNA vaccines.
    Howarth M; Elliott T
    Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression.
    Fong CL; Mok CL; Hui KM
    Gene Ther; 2006 Feb; 13(3):245-56. PubMed ID: 16163376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.
    Voltan R; Castaldello A; Brocca-Cofano E; De Michele R; Triulzi C; Altavilla G; Tondelli L; Laus M; Sparnacci K; Reali E; Gavioli R; Ensoli B; Caputo A
    Vaccine; 2009 Jul; 27(33):4498-507. PubMed ID: 19450649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunogenicity of a multiple epitope DNA vaccine against hepatitis B virus].
    Luo LM; Li M; Xia H; Chen BH; Wang P; Hao WB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):517-21. PubMed ID: 15367337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition.
    Samorski R; Gissmann L; Osen W
    Immunol Lett; 2006 Sep; 107(1):41-9. PubMed ID: 16949679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a molecular explanation for cross-presentation of antigens to the immune system.
    Khor B; Makar RS
    Transfus Med Rev; 2008 Jul; 22(3):188-201. PubMed ID: 18572095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccines against HPV-16 E7-expressing tumour cells.
    De Marco F; Hallez S; Brulet JM; Gesché F; Marzano P; Flamini S; Marcante ML; Venuti A
    Anticancer Res; 2003; 23(2B):1449-54. PubMed ID: 12820408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunol Lett; 2005 Jun; 99(1):85-93. PubMed ID: 15894116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.